E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid

Eur J Clin Microbiol Infect Dis. 2002 Jan;21(1):72-4. doi: 10.1007/s10096-001-0658-0.

Authors

M J Leroi¹, S Siarakas, T Gottlieb

Affiliation

¹ Department of Microbiology and Infectious Diseases, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.

PMID: 11913510
DOI: 10.1007/s10096-001-0658-0

No abstract available

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Acetamides / pharmacology
Anti-Infective Agents / pharmacology*
Aza Compounds*
Clostridioides difficile / drug effects*
Clostridioides difficile / isolation & purification
Clostridium Infections / drug therapy
Clostridium Infections / microbiology
Cross Infection / drug therapy
Cross Infection / microbiology
Diarrhea / drug therapy
Diarrhea / microbiology
Fluoroquinolones*
Fusidic Acid / pharmacology*
Gatifloxacin
Humans
Linezolid
Metronidazole / pharmacology*
Microbial Sensitivity Tests
Moxifloxacin
Oxazolidinones / pharmacology
Quinolines*
Sensitivity and Specificity
Vancomycin / pharmacology*

Substances

Acetamides
Anti-Infective Agents
Aza Compounds
Fluoroquinolones
Oxazolidinones
Quinolines
Metronidazole
Fusidic Acid
Vancomycin
Linezolid
Gatifloxacin
Moxifloxacin